文献速递胃肠外科围术期管理与 ERAS

减重手术人群中贲门失弛缓症的治疗:系统综述与单中心经验

Treatment of achalasia in the bariatric surgery population: a systematic review and single-institution experience.
PubMed 文献 · Surg Endosc · 2020-10-13

该研究结合系统综述与单中心回顾性分析,纳入2012至2019年间13例接受减重手术的贲门失弛缓症患者。结果发现减重术后确诊者症状缓解较差,6例接受腹腔镜Heller肌切开术者中4例复发吞咽困难。提示此类患者治疗具有挑战性,复发常见,需前瞻性研究明确干预时机与顺序。

要点

  • 减重术后确诊贲门失弛缓症者症状缓解常不如术前确诊者。
  • 腹腔镜Heller肌切开术是最常用干预,但术后复发吞咽困难常见。
  • 干预时机(同期或序贯)尚不明确,需个体化决策。

核心结论

  • 减重手术人群中贲门失弛缓症治疗具有挑战性,复发症状常见。
  • 减重术后确诊并治疗贲门失弛缓症的患者症状缓解 tendency 较差。

研究设计与样本

  • 单中心回顾性病历审查,结合系统综述。
  • 2012至2019年共245例贲门失弛缓症患者,其中13例接受减重手术并纳入分析。
  • 按贲门失弛缓症诊断与减重手术的时间顺序分为两组:组1(术前确诊,4例)和组2(术后确诊,9例)。

主要发现

  • 组1中3例接受腹腔镜Heller肌切开术,1例接受经口内镜下肌切开术;均在确诊后5年内行腹腔镜胃旁路术;术后1例出现严重反流需射频治疗,全部吞咽困难缓解。
  • 组2初次减重术式:5例腹腔镜胃旁路术,2例腹腔镜袖状胃切除术,1例十二指肠转位术,1例可调节胃束带术;1例袖状胃切除患者同期行Heller肌切开并转为胃旁路术。
  • 组2平均在减重术后8.3年确诊贲门失弛缓症;干预包括1例气囊扩张、1例肉毒杆菌注射、1例经口内镜下肌切开术、6例腹腔镜Heller肌切开术。
  • 组2中6例接受Heller肌切开术者,4例复发吞咽困难,其中1例需食管切除术。

临床怎么用

  • 对减重手术患者应警惕贲门失弛缓症可能,术前及术后均需评估吞咽症状。
  • 选择干预方式时需考虑减重术式及时序,Heller肌切开术后复发风险较高。

局限性

  • 单中心回顾性设计,样本量小(13例),可能存在选择偏倚。
  • 缺乏前瞻性对照,无法明确最佳干预时机与顺序。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although the link between achalasia and morbid obesity is unclear, the reported prevalence is 0.5-1% in this population. For bariatric surgery patients, optimal type and timing of achalasia intervention is uncertain. METHODS: Patient charts from a single academic institution were retrospectively reviewed. Between 2012 and 2019, 245 patients were diagnosed with achalasia, 13 of whom underwent bariatric surgery and were included. Patients were divided into two groups depending on the timing of their achalasia diagnosis and bariatric surgery. Groups were compared in terms of type and timing of intervention as well as treatment response. RESULTS: Group 1 included 4 patients diagnosed with achalasia before bariatric surgery. Three had laparoscopic Heller myotomy (LHM) and 1 had a per oral endoscopic myotomy (POEM). These patients had laparoscopic gastric bypass (LGB) within 5 years of achalasia diagnosis. Postoperatively, 1 had severe reflux with regurgitation necessitating radiofrequency energy application to the lower esophageal sphincter. All had relief from dysphagia. Group 2 included 9 patients diagnosed with achalasia after bariatric surgery. Achalasia subtypes were evenly distributed. Initial operations were: 5 LGB, 2 laparoscopic sleeve gastrectomy (LSG), 1 duodenal switch (DS), 1 lap band. One LSG patient was converted to LGB concurrently with LHM. On average, achalasia was diagnosed 8.3 years after bariatric surgery. Achalasia interventions included: 1 pneumatic dilation, 1 Botox injection, 1 POEM, 6 LHM. While LHM was the most common procedure, 4 of 6 patients experienced recurrent dysphagia, one of whom required esophagectomy. CONCLUSIONS: Achalasia is a challenging problem in the bariatric surgery population. Recurrent symptoms are common. Patients treated for achalasia after bariatric surgery tended to have worse symptom resolution than those diagnosed prior to bariatric surgery. Additional prospective studies are needed to elucidate whether interventions for achalasia should be performed concurrently or in a particular sequence for optimal results.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Crafts TD, Lyo V, Rajdev P, et al. Treatment of achalasia in the bariatric surgery population: a systematic review and single-institution experience. Surg Endosc. 2020. PMID: 33048227. doi:10.1007/s00464-020-08015-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。